Description
全球邁入高齡化的社會，持續提升醫療需求，在持續追求醫療技術創新及提升醫療品質的趨勢下，將為生技產業帶來長多商機，成為價值投資的指標之一。 這集富蘭克林華美投信鄭永欣經理，要來談談生技股在付2022年的投資展望。 富蘭克林華美投信與國外富蘭克林顧問公司生技研究團隊投資顧問合作，已於5/9啟動募集，「富蘭克林華美生技基金」集合集團資源研究，隨時掌握市場情報，採取由下而上的選股策略，選擇具發展潛力、技術領先且臨床數據及市場發展策略良好的個股！ 建議投資人適時逢低進場布局，積極參與生技題材！ 富蘭克林華美生技基金:https://ftftfund.pse.is/46ywse -- Hosting provided by SoundOn
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News